EMJ Podcast: Advancements in the Treatment of Moderate-to-Severe Atopic Dermatitis

Bonus Episode

Advancements in the Treatment of Moderate-to-Severe Atopic Dermatitis

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the final instalment in a five-part series exploring the subject of atopic dermatitis (AD). Hear from Dr Stephan Weidinger, Professor of Dermatogenetics, Christian-Albrechts-University, Germany, who discusses advancements in the treatment of moderate-to-severe AD, including the nuances of treatment options, long-term strategies, and how the disease affects people’s everyday lives.

Spotify | Apple | Download MP3 (mp3, 29:35 mins)